Shree Ganesh Biotech (india) Share Price
Sector: Crops
0.87 +0.01 (1.16%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
0.86
Today’s High
0.88
52 Week Low
0.80
52 Week High
1.44
Key Metrics
- Market Cap (In Cr) 34.28
- Beta 1.22
- Div. Yield (%) 0
- P/B 0.54
- TTM P/E 45
- Peg Ratio -0.93
- Sector P/E 20.68
- D/E 0
- Open Price 0.87
- Prev Close 0.86
Shree Ganesh Biotech (india) Analysis
Price Analysis
-
1 Week-1.15%
-
3 Months-4.44%
-
6 Month-16.5%
-
YTD-17.31%
-
1 Year-23.89%
Risk Meter
- 32% Low risk
- 32% Moderate risk
- 32% Balanced Risk
- 32% High risk
- 32% Extreme risk
Shree Ganesh Biotech (india) News
Shree Ganesh Biotech India to consider bonus shares issue, stock surges
1 min read . 03 Feb 2022Shree Ganesh Biotech (india) Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 22.96
- Selling/ General/ Admin Expenses Total
- 0.1
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 1.27
- Total Operating Expense
- 24.01
- Operating Income
- -1.05
- Net Income Before Taxes
- 0.39
- Net Income
- 0.28
- Diluted Normalized EPS
- 0.01
- Period
- 2025
- Total Assets
- 63.49
- Total Liabilities
- 0.23
- Total Equity
- 63.26
- Tangible Book Valueper Share Common Eq
- 1.59
- Period
- 2025
- Cashfrom Operating Activities
- -10.21
- Cashfrom Investing Activities
- 9.8
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.41
- Period
- 2024
- Total Revenue
- 20.28
- Selling/ General/ Admin Expenses Total
- 0.3
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.15
- Total Operating Expense
- 20.48
- Operating Income
- -0.2
- Net Income Before Taxes
- 0.85
- Net Income
- 0.62
- Diluted Normalized EPS
- 0.02
- Period
- 2024
- Total Assets
- 73.62
- Total Liabilities
- 10.64
- Total Equity
- 62.98
- Tangible Book Valueper Share Common Eq
- 1.58
- Period
- 2024
- Cashfrom Operating Activities
- 10.16
- Cashfrom Investing Activities
- -10.21
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.05
- Period
- 2023
- Total Revenue
- 62.45
- Selling/ General/ Admin Expenses Total
- 0.3
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.38
- Total Operating Expense
- 60.31
- Operating Income
- 2.15
- Net Income Before Taxes
- 2.71
- Net Income
- 2.04
- Diluted Normalized EPS
- 0.05
- Period
- 2023
- Total Assets
- 79.52
- Total Liabilities
- 17.17
- Total Equity
- 62.36
- Tangible Book Valueper Share Common Eq
- 1.56
- Period
- 2023
- Cashfrom Operating Activities
- 10.54
- Cashfrom Investing Activities
- -10.09
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.44
- Period
- 2022
- Total Revenue
- 72.64
- Selling/ General/ Admin Expenses Total
- 0.29
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.02
- Total Operating Expense
- 69.2
- Operating Income
- 3.45
- Net Income Before Taxes
- 3.5
- Net Income
- 2.53
- Diluted Normalized EPS
- 0.07
- Period
- 2022
- Total Assets
- 93.55
- Total Liabilities
- 33.24
- Total Equity
- 60.32
- Tangible Book Valueper Share Common Eq
- 1.51
- Period
- 2022
- Cashfrom Operating Activities
- 3.57
- Cashfrom Investing Activities
- -3.37
- Cashfrom Financing Activities
- -0.19
- Net Changein Cash
- 0.01
- Period
- 2021
- Total Revenue
- 17.21
- Selling/ General/ Admin Expenses Total
- 0.12
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.01
- Total Operating Expense
- 16.79
- Operating Income
- 0.43
- Net Income Before Taxes
- 0.43
- Net Income
- 0.32
- Diluted Normalized EPS
- 0.01
- Period
- 2021
- Total Assets
- 74.63
- Total Liabilities
- 16.84
- Total Equity
- 57.79
- Tangible Book Valueper Share Common Eq
- 1.45
- Period
- 2021
- Cashfrom Operating Activities
- 2.36
- Cashfrom Investing Activities
- -2.36
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.01
- Period
- 2020
- Total Revenue
- 2.47
- Selling/ General/ Admin Expenses Total
- 0.06
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.6
- Total Operating Expense
- 2.24
- Operating Income
- 0.24
- Net Income Before Taxes
- 0.24
- Net Income
- 0.24
- Diluted Normalized EPS
- 0.01
- Period
- 2020
- Total Assets
- 64.72
- Total Liabilities
- 7.24
- Total Equity
- 57.48
- Tangible Book Valueper Share Common Eq
- 1.44
- Period
- 2020
- Cashfrom Operating Activities
- -1.01
- Cashfrom Investing Activities
- 0.99
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.02
- Period
- 2019
- Total Revenue
- 5.87
- Selling/ General/ Admin Expenses Total
- 0.09
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.63
- Total Operating Expense
- 4.08
- Operating Income
- 1.79
- Net Income Before Taxes
- 1.79
- Net Income
- 1.79
- Diluted Normalized EPS
- 0.04
- Period
- 2019
- Total Assets
- 64.09
- Total Liabilities
- 6.85
- Total Equity
- 57.24
- Tangible Book Valueper Share Common Eq
- 1.44
- Period
- 2019
- Cashfrom Operating Activities
- -0.5
- Cashfrom Investing Activities
- -32.07
- Cashfrom Financing Activities
- 32.58
- Net Changein Cash
- 0.01
- Period
- 2025-03-31
- Total Revenue
- 3.01
- Selling/ General/ Admin Expenses Total
- 0.01
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.88
- Total Operating Expense
- 4.42
- Operating Income
- -1.41
- Net Income Before Taxes
- -0.95
- Net Income
- -0.95
- Diluted Normalized EPS
- -0.02
- Period
- 2025-03-31
- Total Assets
- 63.49
- Total Liabilities
- 0.23
- Total Equity
- 63.26
- Tangible Book Valueper Share Common Eq
- 1.59
- Period
- 2025-03-31
- Cashfrom Operating Activities
- -10.21
- Cashfrom Investing Activities
- 9.8
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.41
- Period
- 2024-12-31
- Total Revenue
- 14.41
- Selling/ General/ Admin Expenses Total
- 0.06
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.12
- Total Operating Expense
- 13.94
- Operating Income
- 0.47
- Net Income Before Taxes
- 0.77
- Net Income
- 0.77
- Diluted Normalized EPS
- 0.02
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 1.98
- Selling/ General/ Admin Expenses Total
- 0.01
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.03
- Total Operating Expense
- 1.96
- Operating Income
- 0.02
- Net Income Before Taxes
- 0.32
- Net Income
- 0.32
- Diluted Normalized EPS
- 0.01
- Period
- 2024-09-30
- Total Assets
- 63.66
- Total Liabilities
- 0.12
- Total Equity
- 63.54
- Tangible Book Valueper Share Common Eq
- 1.59
- Period
- 2024-09-30
- Period
- 2024-06-30
- Total Revenue
- 3.56
- Selling/ General/ Admin Expenses Total
- 0.01
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.24
- Total Operating Expense
- 3.69
- Operating Income
- -0.13
- Net Income Before Taxes
- 0.24
- Net Income
- 0.24
- Diluted Normalized EPS
- 0.01
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 3.78
- Selling/ General/ Admin Expenses Total
- 0.08
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.09
- Total Operating Expense
- 4.3
- Operating Income
- -0.51
- Net Income Before Taxes
- 0.54
- Net Income
- 0.31
- Diluted Normalized EPS
- 0.01
- Period
- 2024-03-31
- Total Assets
- 73.62
- Total Liabilities
- 10.64
- Total Equity
- 62.98
- Tangible Book Valueper Share Common Eq
- 1.58
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 10.16
- Cashfrom Investing Activities
- -10.21
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -0.05
- Period
- 2023-12-31
- Total Revenue
- 4.12
- Selling/ General/ Admin Expenses Total
- 0.03
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.03
- Total Operating Expense
- 4.04
- Operating Income
- 0.09
- Net Income Before Taxes
- 0.09
- Net Income
- 0.09
- Diluted Normalized EPS
- 0
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Shree Ganesh Biotech (india) Technical
Moving Average
SMA
- 5 Day0.86
- 10 Day0.87
- 20 Day0.87
- 50 Day0.9
- 100 Day0.94
- 300 Day1
Shree Ganesh Biotech (india) Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Shiva Global Agro Industries
- 39.01
- -0.8
- -2.01
- 51
- 34.5
- 38.98
- Swojas Foods
- 12.13
- 0.57
- 4.93
- 26.18
- 9.51
- 37.56
- Shree Ganesh Biotech (india)
- 0.87
- 0.01
- 1.16
- 1.44
- 0.8
- 34.28
- Cochin Malabar Estates And Ind
- 178.45
- 5.45
- 3.15
- 245.85
- 130.2
- 31.62
- Hindustan Agrigenetics
- 71
- 1.51
- 2.17
- 93.96
- 40
- 31.24
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Shiva Global Agro Industries
- -
- 0.45
- 3.06
- 0.47
- Swojas Foods
- 12.57
- 5.59
- 15.65
- -
- Shree Ganesh Biotech (india)
- 86
- 0.54
- 1.9
- 2.96
- Cochin Malabar Estates And Ind
- 23.93
- -
- -
- -
- Hindustan Agrigenetics
- -
- 2.54
- 0.78
- 2835.24
Shree Ganesh Biotech (india) Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 22-May-25
- Audited Results
- 04-Feb-25
- Quarterly Results
- 23-Oct-24
- Quarterly Results
- 13-Aug-24
- Quarterly Results
- 30-May-24
- Audited Results
- 13-Feb-24
- Quarterly Results
- 08-Nov-23
- Quarterly Results
- 14-Aug-23
- Quarterly Results
- 30-May-23
- Audited Results
- 21-Feb-23
- Others
- Meeting Date
- Announced on
- Purpose
- 28-Sept-24
- 13-Sept-24
- AGM
- 28-Sept-23
- 07-Sept-23
- AGM
- 27-Sept-22
- 25-Jul-22
- AGM
- 09-Apr-22
- 09-Mar-22
- POM

- Announced on
- Record Date
- Ex-Bonus
- Description
- 07-Mar-22
- 28-Apr-22
- 27-Apr-22
- Bonus issue of equity shares in the ratio of 1:1 of Re. 1/--.
- Ex-Splits
- Old FV
- New FV
- Description
- 10-Feb-22
- 10
- 1
- Stock split from Rs. 10/- to Re. 1/-.
